Using Telehealth to Improve Outcomes in Veterans at Risk for Suicide
NCT ID: NCT03724370
Last Updated: 2022-05-06
Study Results
Results pending
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
Recruitment Status
UNKNOWN
Clinical Phase
NA
Total Enrollment
180 participants
Study Classification
INTERVENTIONAL
Study Start Date
2018-12-14
Study Completion Date
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Overview. The investigators will randomize 120 Veterans in this 3-site trial over 16 months. Eligible Veterans will include those to be discharged for a hospitalization for suicidal ideation. Baseline data collection and randomization will occur at discharge. The 3 month intervention will have study assessments at 2, 4, 8, and 12 weeks post-discharge. The study's primary outcome measure is suicidal ideation (measured with the Beck Scale for Suicidal Ideation\[BSS\] and secondarily with the Columbia Scale for Suicidality C-SSRS).
Intervention Components. The control condition will consist of Veterans randomized to VHA-SRM (Suicide Risk Monitoring). The experimental condition will be the telehealth system (TES) + VHA-SRM (Suicide Risk Monitoring) intervention. Veterans randomized to the telehealth system will receive the Interactive Voice Response (IVR) system monitoring in addition to VHA-SRM and will receive training on how to use the TES from the research coordinator. Veterans can access the IVR as a telephonic device accessed by a local or toll-free number and can use a 'plain old telephone system' (POTS), Cellular phone or Internet phone connected to their phone service provider. Participants will be instructed to interact daily with the TES system daily. Because of safety concerns, questions pertaining to suicidal behavior will be asked daily; to avoid repetition, all other questions will be asked every 3rd day. Once participants complete the questions on the telehealth device, their responses will be automatically uploaded and checked by trained VA Pittsburgh Healthcare System (VAPHS) nurses every 4 hours, during regular daytime hours of 9-5. VAPHS will serve as the central site retrieving downloads for all sites. Color-coded risk triage level designations based on potential responses, provide guidance regarding next steps. The protocol for assessing suicidal patients will follow standard VA procedures, outlined in each medical center's safety plan for suicidal patients.
Intervention Components. The control condition will consist of Veterans randomized to VHA-SRM (Suicide Risk Monitoring). The experimental condition will be the telehealth system (TES) + VHA-SRM (Suicide Risk Monitoring) intervention. Veterans randomized to the telehealth system will receive the Interactive Voice Response (IVR) system monitoring in addition to VHA-SRM and will receive training on how to use the TES from the research coordinator. Veterans can access the IVR as a telephonic device accessed by a local or toll-free number and can use a 'plain old telephone system' (POTS), Cellular phone or Internet phone connected to their phone service provider. Participants will be instructed to interact daily with the TES system daily. Because of safety concerns, questions pertaining to suicidal behavior will be asked daily; to avoid repetition, all other questions will be asked every 3rd day. Once participants complete the questions on the telehealth device, their responses will be automatically uploaded and checked by trained VA Pittsburgh Healthcare System (VAPHS) nurses every 4 hours, during regular daytime hours of 9-5. VAPHS will serve as the central site retrieving downloads for all sites. Color-coded risk triage level designations based on potential responses, provide guidance regarding next steps. The protocol for assessing suicidal patients will follow standard VA procedures, outlined in each medical center's safety plan for suicidal patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Brief Intervention to Reduce Suicide Risk in Military Service Members and Veterans- Study 1
NCT01334541
Suicide Risk | Patient
COMPLETED
Randomized Clinical Trial of Re-Evaluating Suicidal Thoughts in Veterans
NCT05884476
Suicidal Ideation
Suicide, Attempted
RECRUITING
NA
Smartphone App Enhanced Facilitation Among Veterans in a Mental Health Inpatient Setting (Project HOPE)
NCT06378541
Suicide Prevention
Suicide Attempt
Suicidal Ideation
RECRUITING
NA
Suicide Prevention After Community Care Discharge
NCT06596044
Suicide Prevention
RECRUITING
NA
Peer Based Suicide Prevention
NCT04222673
Suicide
COMPLETED
NA
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A subject will be considered enrolled after they sign the consent form, but prior to the initiation of study procedures. After enrollment, subjects will undergo baseline assessments and will be randomized prior to discharge from index hospitalization. The study aims to randomize 120 Veterans in 3-sites over 16-20 months.
Once a Veteran has been identified and referred, a member of the study team will meet with the Veteran on the inpatient unit to obtain consent. The baseline visit may take place all at once or on different days while patients are on the inpatient service. The investigators will attempt to perform baseline assessments as close to discharge as possible in order to obtain a true baseline assessment. However, the investigators may not be able to be certain regarding time of discharge and if this is the case or if discharge is extended, the baseline will be repeated one or more times to ensure that we have baseline data close to the time of discharge.
To assess eligibility, the following will be administered:
1. Folstein Mini Mental Status Exam to assess cognitive impairment.
2. The Beck Scale for Suicidal Ideation (SSI) to assess suicidal ideation.
3. The 17 item Hamilton Depression Rating Scale (HAM-17) to rate depressive symptoms.
4. The Mini International Neuropsychiatric Interview (MINI) to determine diagnoses.
Also administered will be the Sociodemographics Form, Columbia Scale for Suicidality (C-SSRS), Beck Hopelessness Scale©, Brief Addiction Monitor (BAM), Brief Emotional Closeness Questionnaire (ECQ), Brief Medication Questionnaire (BMQ), Hamilton Depression Rating Scale (HAM-D17), Clinical Global Impressions (CGI), and the Medical Outcomes Studies Social Support Survey (MOS-36). Participants that have a diagnosis of Schizophrenia(SZ) or Schizoaffective(SZA) disorder will additionally receive the Scales for the Assessment of Positive and Negative Symptoms (SAPS and SANS). These may be completed any time during the inpatient hospitalization.
In order to obtain a true baseline, these assessments may be administered more than once to obtain the measure as close to the participant's discharge as possible.
Eligible Veterans who complete the assessments will be randomized close to the time of discharge in blocks and stratified by site. When a participant is ready to be randomized, a non-blinded study staff member will access the randomization scheme database/spreadsheet. Staff will click a button to "randomize" and to determine which group they are in. The slot with the group will be provided to the staff member and documented in the database/spreadsheet with the subject identifier (ID) and the date of randomization. At least one of the assessors will be masked, or "blinded," to treatment. The control condition will consist of Veterans randomized to VHA suicide risk management (VHA-SRM). The experimental condition will be the telehealth + VHA suicide risk management (TES+VHA-SRM) intervention.
The intervention is an Interactive Voice Response system, provided by vendor AMC Health. See Appendices 3 and 4. Using the scripts in the protocol, the system will call the patient at the time of day requested by the patient, and ask the questions on the schizophrenia script(for Veterans with schizophrenia or schizoaffective disorder) or the questions on the depression script for all other patients. The patient will answer each question numerically, by either pressing a number or stating the number to the system. The responses will be accessed through a secure web portal maintained by AMC Health, and reviewed Q4 hours by the VAPHS nurses.
The study team will aim to keep an assessor blinded to treatment. This assessor will administer the assessments over follow up.
Veterans randomized to TES+VHA-SRM will receive the IVR system in addition to VHA-SRM and will receive training on how to use the TES from non-blinded research staff, including instructions to contact their providers for any clinical concerns, as well as the research team, or the Veterans Crisis Line. Veterans can use IVR as telephonic device accessed by a local or toll-free number and can use a Plain Old Telephone System (POTS) device connected to their landline or Cellular phone or Internet Protocol phone connected to their phone service provider. Participants will be instructed to interact daily with the TES system daily. Patients will receive the dialogue specific for depression unless they have a diagnosis of SZ/SZA, in which case they will receive the SZ/SZA dialogue. Because of safety concerns, questions pertaining to suicidal behavior will be asked daily; to avoid repetition, all other questions will be asked every 3rd day. Once participants complete the questions on the telehealth device, their responses will be automatically uploaded and checked by trained VAPHS nurses every 4 hours, during regular daytime work hours, 9-5. VAPHS will serve as the central site retrieving downloads for all sites. The website will include responses with color-coded risk triage level designations and staff will receive guidance regarding next steps based on these color codes. The protocol for assessing suicidal patients will follow standard VA procedures, outlined in each medical center's safety plan for suicidal patients.
Veterans randomized to TES+VHA-SRM will be asked to use the IVR system once within a 24 hour period. If an IVR session is not completed within this time frame, the system will automatically call the participant the next morning at a phone number provided by the participant. If the IVR session is not successfully completed after the automatic session is sent, the VAPHS nursing staff will be alerted to this at 12 pm, noon on the website. They will contact the participant's clinician or study staff at that particular site to alert them they have not completed an IVR session. Study staff will track adherence rates to the IVR system.
Veterans randomized to TES+VHA-SRM will have adherence to the telehealth system tracked daily. All subjects will have appointment adherence tracked for 12 weeks post discharge from index hospitalization and psychiatric hospitalizations will be tracked for 12 months post-randomization.
The study team may call the patient's psychiatrist, other clinician, or a significant other (i.e. a family member), or another significant other in the community who the subject has identified and has provided consent for the study team to contact. The team will only contact someone other than the subject's psychiatrist or other clinician if the team has not been able to reach the subject for 48 hours.
All subjects will come in at weeks 2, 4, 8 and 12 following discharge either at the VAPHS outpatient clinics, the VA community based outpatient clinics, Vet centers. They may come in within a 2-week window before or after the expected assessment date.
The following assessments will be administered at follow up: SSI, CSS, HAM-D17, Beck Hopeless Scale, National Institute of Drug Abuse (NIDA) Brief Substance Use Questionnaire, BMQ, and CGI. Participants that have a diagnosis of Schizophrenia or Schizoaffective disorder will additionally receive SAPS and SANS.
In addition to the assessments listed above, week 12 will also administer MOS-36 for all participants and the After Scenario questionnaire for those randomized to TES+VHA-SRM.
During the course of the study, appointment adherence will be tracked for the 12 week of active participation and psychiatric hospitalizations will be tracked for 12 months post-randomization.
Once a Veteran has been identified and referred, a member of the study team will meet with the Veteran on the inpatient unit to obtain consent. The baseline visit may take place all at once or on different days while patients are on the inpatient service. The investigators will attempt to perform baseline assessments as close to discharge as possible in order to obtain a true baseline assessment. However, the investigators may not be able to be certain regarding time of discharge and if this is the case or if discharge is extended, the baseline will be repeated one or more times to ensure that we have baseline data close to the time of discharge.
To assess eligibility, the following will be administered:
1. Folstein Mini Mental Status Exam to assess cognitive impairment.
2. The Beck Scale for Suicidal Ideation (SSI) to assess suicidal ideation.
3. The 17 item Hamilton Depression Rating Scale (HAM-17) to rate depressive symptoms.
4. The Mini International Neuropsychiatric Interview (MINI) to determine diagnoses.
Also administered will be the Sociodemographics Form, Columbia Scale for Suicidality (C-SSRS), Beck Hopelessness Scale©, Brief Addiction Monitor (BAM), Brief Emotional Closeness Questionnaire (ECQ), Brief Medication Questionnaire (BMQ), Hamilton Depression Rating Scale (HAM-D17), Clinical Global Impressions (CGI), and the Medical Outcomes Studies Social Support Survey (MOS-36). Participants that have a diagnosis of Schizophrenia(SZ) or Schizoaffective(SZA) disorder will additionally receive the Scales for the Assessment of Positive and Negative Symptoms (SAPS and SANS). These may be completed any time during the inpatient hospitalization.
In order to obtain a true baseline, these assessments may be administered more than once to obtain the measure as close to the participant's discharge as possible.
Eligible Veterans who complete the assessments will be randomized close to the time of discharge in blocks and stratified by site. When a participant is ready to be randomized, a non-blinded study staff member will access the randomization scheme database/spreadsheet. Staff will click a button to "randomize" and to determine which group they are in. The slot with the group will be provided to the staff member and documented in the database/spreadsheet with the subject identifier (ID) and the date of randomization. At least one of the assessors will be masked, or "blinded," to treatment. The control condition will consist of Veterans randomized to VHA suicide risk management (VHA-SRM). The experimental condition will be the telehealth + VHA suicide risk management (TES+VHA-SRM) intervention.
The intervention is an Interactive Voice Response system, provided by vendor AMC Health. See Appendices 3 and 4. Using the scripts in the protocol, the system will call the patient at the time of day requested by the patient, and ask the questions on the schizophrenia script(for Veterans with schizophrenia or schizoaffective disorder) or the questions on the depression script for all other patients. The patient will answer each question numerically, by either pressing a number or stating the number to the system. The responses will be accessed through a secure web portal maintained by AMC Health, and reviewed Q4 hours by the VAPHS nurses.
The study team will aim to keep an assessor blinded to treatment. This assessor will administer the assessments over follow up.
Veterans randomized to TES+VHA-SRM will receive the IVR system in addition to VHA-SRM and will receive training on how to use the TES from non-blinded research staff, including instructions to contact their providers for any clinical concerns, as well as the research team, or the Veterans Crisis Line. Veterans can use IVR as telephonic device accessed by a local or toll-free number and can use a Plain Old Telephone System (POTS) device connected to their landline or Cellular phone or Internet Protocol phone connected to their phone service provider. Participants will be instructed to interact daily with the TES system daily. Patients will receive the dialogue specific for depression unless they have a diagnosis of SZ/SZA, in which case they will receive the SZ/SZA dialogue. Because of safety concerns, questions pertaining to suicidal behavior will be asked daily; to avoid repetition, all other questions will be asked every 3rd day. Once participants complete the questions on the telehealth device, their responses will be automatically uploaded and checked by trained VAPHS nurses every 4 hours, during regular daytime work hours, 9-5. VAPHS will serve as the central site retrieving downloads for all sites. The website will include responses with color-coded risk triage level designations and staff will receive guidance regarding next steps based on these color codes. The protocol for assessing suicidal patients will follow standard VA procedures, outlined in each medical center's safety plan for suicidal patients.
Veterans randomized to TES+VHA-SRM will be asked to use the IVR system once within a 24 hour period. If an IVR session is not completed within this time frame, the system will automatically call the participant the next morning at a phone number provided by the participant. If the IVR session is not successfully completed after the automatic session is sent, the VAPHS nursing staff will be alerted to this at 12 pm, noon on the website. They will contact the participant's clinician or study staff at that particular site to alert them they have not completed an IVR session. Study staff will track adherence rates to the IVR system.
Veterans randomized to TES+VHA-SRM will have adherence to the telehealth system tracked daily. All subjects will have appointment adherence tracked for 12 weeks post discharge from index hospitalization and psychiatric hospitalizations will be tracked for 12 months post-randomization.
The study team may call the patient's psychiatrist, other clinician, or a significant other (i.e. a family member), or another significant other in the community who the subject has identified and has provided consent for the study team to contact. The team will only contact someone other than the subject's psychiatrist or other clinician if the team has not been able to reach the subject for 48 hours.
All subjects will come in at weeks 2, 4, 8 and 12 following discharge either at the VAPHS outpatient clinics, the VA community based outpatient clinics, Vet centers. They may come in within a 2-week window before or after the expected assessment date.
The following assessments will be administered at follow up: SSI, CSS, HAM-D17, Beck Hopeless Scale, National Institute of Drug Abuse (NIDA) Brief Substance Use Questionnaire, BMQ, and CGI. Participants that have a diagnosis of Schizophrenia or Schizoaffective disorder will additionally receive SAPS and SANS.
In addition to the assessments listed above, week 12 will also administer MOS-36 for all participants and the After Scenario questionnaire for those randomized to TES+VHA-SRM.
During the course of the study, appointment adherence will be tracked for the 12 week of active participation and psychiatric hospitalizations will be tracked for 12 months post-randomization.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Suicide
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
Allocation Method
RANDOMIZED
Intervention Model
PARALLEL
Primary Study Purpose
OTHER
Blinding Strategy
SINGLE
Outcome Assessors
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TES+ VHA-SRM
Telehealth monitoring system (TES) will be added to the VA suicide risk management system (VHA-SRM)
Group Type
EXPERIMENTAL
Telehealth Monitoring System
Intervention Type
BEHAVIORAL
TES will be conducted daily via Interactive Voice Response System (IVRS) during the 12 week study period.TES will be added to VHA-SRM.
VHA-SRM
Intervention Type
OTHER
Veterans Health Administration Suicide Risk Management supportive services will be provided to participant during the 12 weeks of study participation.
VHA-SRM
VHA-SRM will be active comparator
Group Type
ACTIVE_COMPARATOR
VHA-SRM
Intervention Type
OTHER
Veterans Health Administration Suicide Risk Management supportive services will be provided to participant during the 12 weeks of study participation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Telehealth Monitoring System
TES will be conducted daily via Interactive Voice Response System (IVRS) during the 12 week study period.TES will be added to VHA-SRM.
Intervention Type
BEHAVIORAL
VHA-SRM
Veterans Health Administration Suicide Risk Management supportive services will be provided to participant during the 12 weeks of study participation.
Intervention Type
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Veterans \> 18 years old;
2. any diagnosis as long as participants exhibit at least mild depressive symptoms, i.e., a Hamilton 17-item depression 30 score \>8; this includes patients with schizophrenia/schizoaffective disorder;
3. score \>1 on items 4 or 5 on the SSI ; which assesses active or passive suicidal ideation, respectively.-
2. any diagnosis as long as participants exhibit at least mild depressive symptoms, i.e., a Hamilton 17-item depression 30 score \>8; this includes patients with schizophrenia/schizoaffective disorder;
3. score \>1 on items 4 or 5 on the SSI ; which assesses active or passive suicidal ideation, respectively.-
Exclusion Criteria
1. Cognitive problems that would interfere with Veterans' ability to manage the TES system (e.g., neurocognitive d/o, significant traumatic brain injury, or a Folstein Mini Mental Status Exam score \<22) or serious motor dexterity problems;
2. Veterans without phone access.
2. Veterans without phone access.
Minimum Eligible Age
18 Years
Eligible Sex
ALL
Accepts Healthy Volunteers
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
American Foundation for Suicide Prevention
OTHER
Sponsor Role
collaborator
VA Pittsburgh Healthcare System
FED
Sponsor Role
lead
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gretchen L. Haas, PhD
PI
Responsibility Role
PRINCIPAL_INVESTIGATOR
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gretchen L Haas, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
VA Pittsburgh Healthcare System
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VA NY Harbor Healthcare System, Manhattan Campus
New York, New York, United States
Site Status
RECRUITING
James J. Peters Medical Center
The Bronx, New York, United States
Site Status
RECRUITING
Countries
Review the countries where the study has at least one active or historical site.
United States
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Kemp, J & Bossarte R. (2013). Suicide data report: 2012. Department of Veterans Affairs, Mental Health Services, Suicide Prevention Program.
Reference Type
BACKGROUND
Bruce ML. Suicide risk and prevention in veteran populations. Ann N Y Acad Sci. 2010 Oct;1208:98-103. doi: 10.1111/j.1749-6632.2010.05697.x.
Reference Type
BACKGROUND
Zivin K, Kim HM, McCarthy JF, Austin KL, Hoggatt KJ, Walters H, Valenstein M. Suicide mortality among individuals receiving treatment for depression in the Veterans Affairs health system: associations with patient and treatment setting characteristics. Am J Public Health. 2007 Dec;97(12):2193-8. doi: 10.2105/AJPH.2007.115477. Epub 2007 Oct 30.
Reference Type
BACKGROUND
Report of the Blue Ribbon Work Group on Suicide Prevention in the Veteran Population. Washington, DC: U.S. Department of Veterans Affairs.
Reference Type
BACKGROUND
Department of Veterans Affairs, Inpatient Mental Health Services, VHA Handbook 1160.06, 9/16/2013
Reference Type
BACKGROUND
Desai RA, Dausey DJ, Rosenheck RA. Mental health service delivery and suicide risk: the role of individual patient and facility factors. Am J Psychiatry. 2005 Feb;162(2):311-8. doi: 10.1176/appi.ajp.162.2.311.
Reference Type
BACKGROUND
Valenstein M, Eisenberg D, McCarthy JF, Austin KL, Ganoczy D, Kim HM, Zivin K, Piette JD, Olfson M, Blow FC. Service implications of providing intensive monitoring during high-risk periods for suicide among VA patients with depression. Psychiatr Serv. 2009 Apr;60(4):439-44. doi: 10.1176/ps.2009.60.4.439.
Reference Type
BACKGROUND
Hoffmire CA, Kemp JE, Bossarte RM. Changes in Suicide Mortality for Veterans and Nonveterans by Gender and History of VHA Service Use, 2000-2010. Psychiatr Serv. 2015 Sep;66(9):959-65. doi: 10.1176/appi.ps.201400031. Epub 2015 May 1.
Reference Type
BACKGROUND
The Assessment and Management of Risk for Suicide Working Group. 2013. VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide. Retrieved from: http://www.healthquality.va.
Reference Type
BACKGROUND
Blow FC, Bohnert AS, Ilgen MA, Ignacio R, McCarthy JF, Valenstein MM, Knox KL. Suicide mortality among patients treated by the Veterans Health Administration from 2000 to 2007. Am J Public Health. 2012 Mar;102 Suppl 1(Suppl 1):S98-104. doi: 10.2105/AJPH.2011.300441.
Reference Type
BACKGROUND
McCarthy JF, Valenstein M, Kim HM, Ilgen M, Zivin K, Blow FC. Suicide mortality among patients receiving care in the veterans health administration health system. Am J Epidemiol. 2009 Apr 15;169(8):1033-8. doi: 10.1093/aje/kwp010. Epub 2009 Feb 27.
Reference Type
BACKGROUND
Gibbons RD, Brown CH, Hur K, Davis J, Mann JJ. Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine. Arch Gen Psychiatry. 2012 Jun;69(6):580-7. doi: 10.1001/archgenpsychiatry.2011.2048.
Reference Type
BACKGROUND
Almeida OP, Pirkis J, Kerse N, Sim M, Flicker L, Snowdon J, Draper B, Byrne G, Goldney R, Lautenschlager NT, Stocks N, Alfonso H, Pfaff JJ. A randomized trial to reduce the prevalence of depression and self-harm behavior in older primary care patients. Ann Fam Med. 2012 Jul-Aug;10(4):347-56. doi: 10.1370/afm.1368.
Reference Type
BACKGROUND
Tarrier N, Taylor K, Gooding P. Cognitive-behavioral interventions to reduce suicide behavior: a systematic review and meta-analysis. Behav Modif. 2008 Jan;32(1):77-108. doi: 10.1177/0145445507304728.
Reference Type
BACKGROUND
Valenstein M, Kim HM, Ganoczy D, Eisenberg D, Pfeiffer PN, Downing K, Hoggatt K, Ilgen M, Austin KL, Zivin K, Blow FC, McCarthy JF. Antidepressant agents and suicide death among US Department of Veterans Affairs patients in depression treatment. J Clin Psychopharmacol. 2012 Jun;32(3):346-53. doi: 10.1097/JCP.0b013e3182539f11.
Reference Type
BACKGROUND
Bostwick JM, Pankratz VS. Affective disorders and suicide risk: a reexamination. Am J Psychiatry. 2000 Dec;157(12):1925-32. doi: 10.1176/appi.ajp.157.12.1925.
Reference Type
BACKGROUND
Godleski L, Nieves JE, Darkins A, Lehmann L. VA telemental health: suicide assessment. Behav Sci Law. 2008;26(3):271-86. doi: 10.1002/bsl.811.
Reference Type
BACKGROUND
Valenstein M, Kim HM, Ganoczy D, McCarthy JF, Zivin K, Austin KL, Hoggatt K, Eisenberg D, Piette JD, Blow FC, Olfson M. Higher-risk periods for suicide among VA patients receiving depression treatment: prioritizing suicide prevention efforts. J Affect Disord. 2009 Jan;112(1-3):50-8. doi: 10.1016/j.jad.2008.08.020. Epub 2008 Oct 22.
Reference Type
BACKGROUND
While D, Bickley H, Roscoe A, Windfuhr K, Rahman S, Shaw J, Appleby L, Kapur N. Implementation of mental health service recommendations in England and Wales and suicide rates, 1997-2006: a cross-sectional and before-and-after observational study. Lancet. 2012 Mar 17;379(9820):1005-12. doi: 10.1016/S0140-6736(11)61712-1. Epub 2012 Feb 2.
Reference Type
BACKGROUND
Mishara BL, Chagnon F, Daigle M, Balan B, Raymond S, Marcoux I, Bardon C, Campbell JK, Berman A. Which helper behaviors and intervention styles are related to better short-term outcomes in telephone crisis intervention? Results from a Silent Monitoring Study of Calls to the U.S. 1-800-SUICIDE Network. Suicide Life Threat Behav. 2007 Jun;37(3):308-21. doi: 10.1521/suli.2007.37.3.308.
Reference Type
BACKGROUND
Kasckow J, Zickmund S, Rotondi A, Mrkva A, Gurklis J, Chinman M, Fox L, Loganathan M, Hanusa B, Haas G. Development of telehealth dialogues for monitoring suicidal patients with schizophrenia: consumer feedback. Community Ment Health J. 2014 Apr;50(3):339-42. doi: 10.1007/s10597-012-9589-8. Epub 2013 Jan 10.
Reference Type
BACKGROUND
De Vito Dabbs A, Myers BA, Mc Curry KR, Dunbar-Jacob J, Hawkins RP, Begey A, Dew MA. User-centered design and interactive health technologies for patients. Comput Inform Nurs. 2009 May-Jun;27(3):175-83. doi: 10.1097/NCN.0b013e31819f7c7c.
Reference Type
BACKGROUND
Rubin J. (1994). Handbook of Usability Testing: How to Plan, Design, and Conduct Effective Tests. New York, NY: John Wiley & Sons, Inc.
Reference Type
BACKGROUND
Gould JD, Lewis C. (1985). Designing for usability: key principles and what designers think. Commun ACM. 2:300-311.
Reference Type
BACKGROUND
Kasckow J, Zickmund S, Rotondi A, Welch A, Gurklis J, Chinman M, Fox L, Haas GL. Optimizing Scripted Dialogues for an e-Health Intervention for Suicidal Veterans with Major Depression. Community Ment Health J. 2015 Jul;51(5):509-12. doi: 10.1007/s10597-014-9775-y. Epub 2014 Oct 24.
Reference Type
BACKGROUND
Kasckow J, Gao S, Hanusa B, Rotondi A, Chinman M, Zickmund S, Gurklis J, Fox L, Cornelius J, Richmond I, Haas GL. Telehealth Monitoring of Patients with Schizophrenia and Suicidal Ideation. Suicide Life Threat Behav. 2015 Oct;45(5):600-611. doi: 10.1111/sltb.12154. Epub 2015 Feb 17.
Reference Type
BACKGROUND
Beck AT, Kovacs M, Weissman A. Assessment of suicidal intention: the Scale for Suicide Ideation. J Consult Clin Psychol. 1979 Apr;47(2):343-52. doi: 10.1037//0022-006x.47.2.343. No abstract available.
Reference Type
BACKGROUND
Posner K, Brown GK, Stanley B, Brent DA, Yershova KV, Oquendo MA, Currier GW, Melvin GA, Greenhill L, Shen S, Mann JJ. The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry. 2011 Dec;168(12):1266-77. doi: 10.1176/appi.ajp.2011.10111704.
Reference Type
BACKGROUND
HAMILTON M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960 Feb;23(1):56-62. doi: 10.1136/jnnp.23.1.56. No abstract available.
Reference Type
BACKGROUND
Beck AT, Weissman A, Lester D, Trexler L. The measurement of pessimism: the hopelessness scale. J Consult Clin Psychol. 1974 Dec;42(6):861-5. doi: 10.1037/h0037562. No abstract available.
Reference Type
BACKGROUND
MacArthur Sociodemographic Questionnaire. (2008). The Regents of the University of California
Reference Type
BACKGROUND
Screening for Drug Use in General Medicine: Resource Guide. National Institute on Drug Abuse.
Reference Type
BACKGROUND
Andreason N. Scale for Assessment of Positive Symptoms (SAPS). (1984). University of Iowa, Department of Psychiatry, Iowa City, Iowa.
Reference Type
BACKGROUND
Svarstad BL, Chewning BA, Sleath BL, Claesson C. The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns. 1999 Jun;37(2):113-24. doi: 10.1016/s0738-3991(98)00107-4.
Reference Type
BACKGROUND
Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med. 1991;32(6):705-14. doi: 10.1016/0277-9536(91)90150-b.
Reference Type
BACKGROUND
Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189-98. doi: 10.1016/0022-3956(75)90026-6. No abstract available.
Reference Type
BACKGROUND
American Psychiatric Association. Structured Clinical Interview for DSM-5 (SCID-5). Arlington, 2015.
Reference Type
BACKGROUND
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LSRG-0-060-15
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.
High Risk Suicidal Behavior in Veterans
NCT02462694
COMPLETED
NA
Suicide Risk Interventions
NCT05931289
RECRUITING
PHASE2
ACT for Life: a Brief Intervention for Maximizing Recovery After Suicidal Crises
NCT02751983
COMPLETED
NA
Examining the Efficacy of a Digital Therapeutic to Prevent Suicidal Behaviors
NCT06318962
RECRUITING
NA
Motivational Interviewing to Address Suicidal Ideation for Veterans at High Risk for Suicide
NCT05256940
RECRUITING
NA
Veterans Coordinated Community Care (3C) Study
NCT05272176
ACTIVE_NOT_RECRUITING
NA
Motivational Interviewing to Prevent Suicide in High Risk Veterans
NCT01544127
COMPLETED
NA
Adaptive Implementation Intervention for VA Suicide Risk Identification Strategy
NCT04243330
COMPLETED
NA
Increasing Treatment Seeking Among Suicidal Veterans Calling the Crisis Line
NCT01771965
COMPLETED
NA
Patient and Provider Outcomes of E-Learning Training in Collaborative Assessment and Management of Suicidality
NCT00905827
COMPLETED
NA
Public Messaging to Increase Treatment Seeking for Veterans at Risk for Suicide
NCT04784663
COMPLETED
NA
Testing the Efficacy of ACT for Life
NCT04829682
ENROLLING_BY_INVITATION
NA
Teachable Moment Brief Intervention for Veterans Following a Suicide Attempt
NCT03533075
COMPLETED
NA
Suicide Prevention in Rural Veterans During High-risk Care Transition Scenarios
NCT04054947
COMPLETED
NA
Randomized Controlled and Prospective Trial of a Cohort of People Who Made a Suicide Attempt
NCT01176929
COMPLETED
NA
Couple-Based Crisis Safety Planning
NCT07012824
NOT_YET_RECRUITING
NA
Veterans Coping Long-term With Active Suicide
NCT01894841
COMPLETED
NA
Group ("Project Life Force") vs. Individual Suicide Safety Planning RCT
NCT03653637
COMPLETED
NA
A Study of a Smartphone-based Intervention for Suicidal Inpatients
NCT03121742
WITHDRAWN
NA
A Novel Peer-Delivered Recovery-Focused Suicide Prevention Intervention for Veterans With Serious Mental Illness
NCT05537376
RECRUITING
NA
Improving Caregivers' Ability to Manage Life Stress
NCT05539352
WITHDRAWN
NA
Promoting Safety Plan and Coping Strategy Use Among Adults With Suicidal Thoughts
NCT05791643
COMPLETED
NA
SAFER: A Brief Intervention Involving Family Members in Suicide Safety Planning
NCT03034863
COMPLETED
NA
Operation Worth Living Project With Suicidal Soldiers at Ft. Stewart
NCT01300169
COMPLETED
NA
Brief Interventions for Short-Term Suicide Risk Reduction in Military Populations
NCT02042131
COMPLETED
NA